Ultrahuman, a fast-growing metabolic fitness platform, announced that it has raised $17.5 million to aid over a billion people worldwide who suffer from a metabolic health problem. This sums up to a total amount of $25 million.

The metabolic health problem is without a doubt one of the most serious healthcare issues in today’s world. A metabolic health condition affects over a billion individuals worldwide.
Metabolic abnormalities are responsible for over 85 percent of all chronic diseases worldwide.

People would be better able to make informed decisions about what they eat and how active they are if they knew how diet and exercise affect their metabolic health. The method is a non-geographic, non-diet approach to helping individuals eat and exercise better.

Mohit Kumar and Vatsal Singhal founded Ultrahuman after co-founding Runnr, which ultimately merged with Zomato. Mohit is a cycling enthusiast, biohacker, and Brazilian Jiu-Jitsu practitioner. Vatsal is a biohacker and a crossfit enthusiast. Mohit was training at one of the world's largest MMA camps (Tiger Muay Thai). There, he saw athletes use data, recovery tools, and regimens to train effectively. He then teamed up with Vatsal to create a concept for Ultrahuman in which they can make people's fitness journeys more personalized and impactful.

Ultrahuman is one of the most advanced metabolic fitness platforms in the world. Instead of diets and stringent exercise routines, it uses quick nudges and detailed health insights to help people form long-term habits and changes.

The platform is dedicated to bringing metabolic fitness to millions of individuals throughout the world.

“We are excited to partner with Mohit and Vatsal, founders of Ultrahuman. We believe they can transform the way people view personal wellness globally. Their thoughtfulness around UI / design and consumer experience is inspiring. We are thrilled to back what could be a pioneering biomarker-driven global healthcare business. Their dual obsessiveness around product engineering and customer experience is already showing result in terms of product-market fit and retention”, says Navroz D. Udwadia, Co-Founder, Falcon Edge Capital.

Ravi Mehta, Founder and MD Steadview Capital, says “we are excited to be a part of Ultrahuman’s journey as it takes what we believe to be a disruptive approach to personal wellness. Ultrahuman’s biosensor-enabled, data-first model, in our view, is the future of any personalized healthcare ecosystem”.

“We at Nexus are super excited about Ultrahuman’s biomarker-based approach to build hyper- personalized diet and exercise journeys for users. We are seeing a very strong pull for Ultrahuman’s Cyborg platform globally and feel that it will be a foundational approach to personal wellness in the years to come”, adds Sameer Brij Verma, MD Nexus Venture Partners.

“Mohit and team have taken their personal fitness journeys and translated them to a world class product and experience in just over a year. We expect Ultrahuman to help shape how health is proactively monitored across global audiences”, says Karthik Reddy, Founder, Blume Ventures.

The funding will be utilized to expand their geographical reach and develop their biomarker technology.

The Series B funding came from Alpha Wave Incubation (AWI), which is backed by DisruptAD and managed by Falcon Edge, Steadview Capital, Nexus Venture Partners, Blume Ventures and Utsav Somani’s iSeed fund. Marquee founders and angel investors also participated including Tiger Global’s Scott Schleifer, Sandeep Singhal, Kunal Shah, Sujeet Kumar, Deepinder Goyal, Gunjan Patidar, Gaurav Munjal, Revant Bhate, Mohit Gupta, Vikram Dhingra and Roman Saini.